Literature DB >> 16167057

CD33 is expressed on plasma cells of a significant number of myeloma patients, and may represent a therapeutic target.

N Robillard, S Wuillème, L Lodé, F Magrangeas, S Minvielle, H Avet-Loiseau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16167057     DOI: 10.1038/sj.leu.2403948

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  The colorful landscape of multiple myeloma.

Authors:  Eli Muchtar; Morie A Gertz
Journal:  Leuk Lymphoma       Date:  2019-02-27

Review 2.  Immunophenotyping in multiple myeloma and related plasma cell disorders.

Authors:  Shaji Kumar; Teresa Kimlinger; William Morice
Journal:  Best Pract Res Clin Haematol       Date:  2010-09       Impact factor: 3.020

3.  Small-lymphoid cells and myeloid antigen expression in a patient with IgG myeloma: A case report.

Authors:  Pengjun Jiang; Wen Xia; Xuemei Sun; Xingbin Dai; Lin Li
Journal:  Oncol Lett       Date:  2016-02-08       Impact factor: 2.967

4.  Biclonal light chain gammopathy with aberrant CD33 expression in secondary plasma cell leukemia.

Authors:  Michael Gentry; Mark Pettenati; Changlee S Pang
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

5.  A single-tube multiparameter seven-colour flow cytometry strategy for the detection of malignant plasma cells in multiple myeloma.

Authors:  N Robillard; M C Béné; P Moreau; S Wuillème
Journal:  Blood Cancer J       Date:  2013-08-16       Impact factor: 11.037

Review 6.  Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma.

Authors:  Najmaldin Saki; Saeid Abroun; Saeideh Hajizamani; Fakher Rahim; Mohammad Shahjahani
Journal:  Cell J       Date:  2014-05-25       Impact factor: 2.479

7.  Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin.

Authors:  Michihiro Ono; Rishu Takimoto; Takahiro Osuga; Yutaka Okagawa; Masahiro Hirakawa; Makoto Yoshida; Yohei Arihara; Naoki Uemura; Naoki Hayasaka; Shogo Miura; Teppei Matsuno; Fumito Tamura; Yasushi Sato; Tsutomu Sato; Satoshi Iyama; Koji Miyanishi; Kohichi Takada; Masayoshi Kobune; Junji Kato
Journal:  Oncotarget       Date:  2016-06-21

8.  Immunophenotype of normal and myelomatous plasma-cell subsets.

Authors:  Nelly Robillard; Soraya Wuillème; Philippe Moreau; Marie C Béné
Journal:  Front Immunol       Date:  2014-03-31       Impact factor: 7.561

9.  Expression of myeloid antigen in neoplastic plasma cells is related to adverse prognosis in patients with multiple myeloma.

Authors:  Hyoeun Shim; Joo Hee Ha; Hyewon Lee; Ji Yeon Sohn; Hyun Ju Kim; Hyeon-Seok Eom; Sun-Young Kong
Journal:  Biomed Res Int       Date:  2014-06-04       Impact factor: 3.411

Review 10.  Current applications of multiparameter flow cytometry in plasma cell disorders.

Authors:  T Jelinek; R Bezdekova; M Zatopkova; L Burgos; M Simicek; T Sevcikova; B Paiva; R Hajek
Journal:  Blood Cancer J       Date:  2017-10-20       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.